Drug class
Intravenous ferric iron–carbohydrate complex; parenteral iron replacement agent
Mechanism of action
A stable iron(III)-hydroxide complex with derisomaltose carbohydrate. After intravenous administration, iron is taken up by reticuloendothelial cells and released for transferrin binding, haemoglobin synthesis and replenishment of iron stores; it is not a simple iron salt.
General use cases
- Treatment of iron-deficiency anaemia in adults who have intolerance to oral iron or have had an unsatisfactory response to oral iron
- Use in adults with non-dialysis-dependent chronic kidney disease or other specified causes of iron deficiency according to the product label
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
